274 related articles for article (PubMed ID: 19237719)
1. Risk of immune thrombocytopenic purpura and autoimmune hemolytic anemia among 120 908 US veterans with hepatitis C virus infection.
Chiao EY; Engels EA; Kramer JR; Pietz K; Henderson L; Giordano TP; Landgren O
Arch Intern Med; 2009 Feb; 169(4):357-63. PubMed ID: 19237719
[TBL] [Abstract][Full Text] [Related]
2. Risk of venous thromboembolism occurrence among adults with selected autoimmune diseases: a study among a U.S. cohort of commercial insurance enrollees.
Yusuf HR; Hooper WC; Grosse SD; Parker CS; Boulet SL; Ortel TL
Thromb Res; 2015 Jan; 135(1):50-7. PubMed ID: 25456001
[TBL] [Abstract][Full Text] [Related]
3. Severe autoimmune cytopenias in treatment-naive hepatitis C virus infection: clinical description of 16 cases.
Dufour JF; Pradat P; Ruivard M; Hot A; Dumontet C; Broussolle C; Trepo C; Sève P
Eur J Gastroenterol Hepatol; 2009 Mar; 21(3):245-53. PubMed ID: 19279468
[TBL] [Abstract][Full Text] [Related]
4. Rituximab in the treatment of refractory autoimmune cytopenias in adults.
Narat S; Gandla J; Hoffbrand AV; Hughes RG; Mehta AB
Haematologica; 2005 Sep; 90(9):1273-4. PubMed ID: 16154853
[TBL] [Abstract][Full Text] [Related]
5. Rituximab for immune cytopenia in adults: idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and Evans syndrome.
Shanafelt TD; Madueme HL; Wolf RC; Tefferi A
Mayo Clin Proc; 2003 Nov; 78(11):1340-6. PubMed ID: 14601692
[TBL] [Abstract][Full Text] [Related]
6. Combined autoimmune cytopenias.
Martino R; Muñiz-Díaz E; Arilla M; Ibáñez M; Altés A; Guanyabens C; Madoz P
Haematologica; 1995; 80(4):305-10. PubMed ID: 7590498
[TBL] [Abstract][Full Text] [Related]
7. Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study.
Dierickx D; Verhoef G; Van Hoof A; Mineur P; Roest A; Triffet A; Kentos A; Pierre P; Boulet D; Bries G; Lê PQ; Janssens A; Delannoy A
J Intern Med; 2009 Nov; 266(5):484-91. PubMed ID: 19549092
[TBL] [Abstract][Full Text] [Related]
8. Immune-mediated hemolytic anemia and thrombocytopenia in clonal B-cell disorders: a review.
Durani U; Go RS; Kay NE
Clin Adv Hematol Oncol; 2018 Oct; 16(10):670-676. PubMed ID: 30543597
[TBL] [Abstract][Full Text] [Related]
9. Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus.
Giordano TP; Henderson L; Landgren O; Chiao EY; Kramer JR; El-Serag H; Engels EA
JAMA; 2007 May; 297(18):2010-7. PubMed ID: 17488966
[TBL] [Abstract][Full Text] [Related]
10. Viral-associated immune thrombocytopenic purpura.
Liebman HA
Hematology Am Soc Hematol Educ Program; 2008; ():212-8. PubMed ID: 19074085
[TBL] [Abstract][Full Text] [Related]
11. Presence of Idiopathic Thrombocytopenic Purpura and autoimmune hemolytic anemia in the patients with common variable immunodeficiency.
Ramyar A; Aghamohammadi A; Moazzami K; Rezaei N; Yeganeh M; Cheraghi T; Pouladi N; Heydari G; Abolhassani H; Amirzargar AA; Parvaneh N; Moin M
Iran J Allergy Asthma Immunol; 2008 Sep; 7(3):169-75. PubMed ID: 18780952
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune haemolytic anaemia and immune thrombocytopenia following SARS-CoV-2 and non-SARS-CoV-2 vaccination: 32 Years of passive surveillance data.
Jacobs JW; Booth GS; Guarente J; Schlafer D; Zheng L; Adkins BD
Br J Haematol; 2023 Apr; 201(2):227-233. PubMed ID: 36564040
[TBL] [Abstract][Full Text] [Related]
13. Immune Thrombocytopenic Purpura Complicated by Hepatitis C Virus-related Membranoproliferative Glomerulonephritis after Rituximab Therapy.
Kubodera A; Kume A; Hayashi K; Shimizu R; Miyakawa A; Miyauchi Y; Suzuki Y; Tanaka H
Intern Med; 2021 Aug; 60(15):2469-2473. PubMed ID: 33583904
[TBL] [Abstract][Full Text] [Related]
14. Effect of addition of statins to antiviral therapy in hepatitis C virus-infected persons: Results from ERCHIVES.
Butt AA; Yan P; Bonilla H; Abou-Samra AB; Shaikh OS; Simon TG; Chung RT; Rogal SS;
Hepatology; 2015 Aug; 62(2):365-74. PubMed ID: 25847403
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus infection and autoimmune thrombocytopenic purpura.
Pawlotsky JM; Bouvier M; Fromont P; Deforges L; Duval J; Dhumeaux D; Bierling P
J Hepatol; 1995 Dec; 23(6):635-9. PubMed ID: 8750160
[TBL] [Abstract][Full Text] [Related]
16. Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopenic purpura: a population-based cohort study.
Zhu FX; Huang JY; Ye Z; Wen QQ; Wei JC
Ann Rheum Dis; 2020 Jun; 79(6):793-799. PubMed ID: 32241798
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C Virus (HCV) Treatment With Directly Acting Agents Reduces the Risk of Incident Diabetes: Results From Electronically Retrieved Cohort of HCV Infected Veterans (ERCHIVES).
Butt AA; Yan P; Aslam S; Shaikh OS; Abou-Samra AB
Clin Infect Dis; 2020 Mar; 70(6):1153-1160. PubMed ID: 30977808
[TBL] [Abstract][Full Text] [Related]
18. Idiopathic thrombocytopenic purpura and autoimmune hemolytic anemia in Hodgkin's disease.
Xiros N; Binder T; Anger B; Böhlke J; Heimpel H
Eur J Haematol; 1988 May; 40(5):437-41. PubMed ID: 3378597
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of ITP and AIHA in CVID: A systematic literature review].
Lacombe V; Lozac'h P; Orvain C; Lavigne C; Miot C; Pellier I; Urbanski G
Rev Med Interne; 2019 Aug; 40(8):491-500. PubMed ID: 31101329
[TBL] [Abstract][Full Text] [Related]
20. Incidence and Progression of Chronic Kidney Disease After Hepatitis C Seroconversion: Results from ERCHIVES.
Rogal SS; Yan P; Rimland D; Lo Re V; Al-Rowais H; Fried L; Butt AA;
Dig Dis Sci; 2016 Mar; 61(3):930-6. PubMed ID: 26526451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
